United Kingdom joins France in push to hand vaccines to poorer nations

United Kingdom joins France in push to hand vaccines to poorer nations

Johnson confirmed Britain will be sending all of its surplus vaccines to COVAX, a development that could place Trudeau in a hot seat because Canada is the only G7 country using its membership in the program to get extra vaccines for its own population.

Countries need to cooperate in implementing effective pandemic response and vaccination strategies, treating Covid-19 vaccines as a mutual asset of the worldwide community, ensuring affordable vaccines for all and giving priority to groups at high risk of infection and those on the front lines in the fight against the pandemic, the deputy PM, who is also Vietnam's Foreign Affairs Minister, said as he attended an online meeting of the United Nations Security Council on Wednesday.

World Health Organization is helping countries ramp-up sequencing capacities to detect new variants. Among health-care workers who got the vaccine, symptomatic infections were reduced by 85% in the 15 to 28 days after the first dose, compared with those who didn't get a shot, according to the report in The Lancet medical journal.

The doses of NVX-CoV-2373 for COVAX will be manufactured and distributed by Novavax and the Serum Institute of India (SII) - Novavax has licensed its technology for NVX-CoV2372 to the SII with no upfront, milestone or technology transfer payments.

"A small South African study has found the vaccine was not very effective against mild and moderate cases infected with the 501Y.V2 variant". Approximately 12,500 residents were to receive an email or text message telling them of the delay, Mayor Eric Garcetti said in a statement Thursday.

Last week, the White House said it was wary of those efforts.

COVAX is the vaccine pillar of the WHO's ACT Accelerator - a collaborative initiative co-led by Gavi, the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI) that is aiming to accelerate the development, production and equitable access to COVID-19 tests, treatments and vaccines. That's on top of the 548 million pounds ($766 million) the country has already donated to the program, which is aimed at supplying some of the world's poorest nations with inoculations.

Underlining the political and moral necessity of acting quickly, Macron said: "We are allowing the idea to take hold [that] hundreds of millions of vaccines are being given in rich countries and that we are not starting in poor countries". COVAX now includes more than 190 participating economies. "It's not a power game it's a matter of public health".

Building on the early information provided in the interim distribution forecast published on February 3, 2021, COVAX will now complete the process of final Q1/Q2 allocations of the AstraZeneca/Oxford vaccine to Facility participants.

The original was co-developed by the University of Oxford and AstraZeneca plc. That time-line may be too ambitious, said Salim Abdool Karim, who co-chairs the health minister's ministerial advisory committee on Covid-19.

Asked about Macron's comments and the timeline on donations, another official said, "There are a lot of options on the table, but I don't think we should get locked down in what we might do once the USA population is vaccinated". However, this remains to be demonstrated in clinical trials and post-implementation evaluation.

Related Articles